The USFDA approves Glenmark Pharma's Tacrolimus Ointment

The generic version of Leo Pharma AS's Protopic1 Ointment, 0.03%, Tacrolimus Ointment, 0.03%, has been given final approval by the United States Food & Drug Administration (USFDA).

Glenmark Pharmaceuticals Inc., USA will sell Tacrolimus Ointment, 0.03%, in the US.

Glenmark now has 184 medications in its portfolio that are approved for sale in the US market, and 51 ANDA’s pending approval with the U.S. FDA.

The generic version of AstraZeneca's Onglyza1 tablets, Saxagliptin tablets (2.5 mg and 5 mg), was approved by the US Food & Drug Administration (US FDA) earlier this month.

Source: Media Reports